Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Presbia Flexivue microlens: three years follow-up results and outcomes

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Refractive Corneal Inlays

Session Date/Time: Monday 12/09/2016 | 15:00-16:30

Paper Time: 15:00

Venue: Poster Village: Pod 2

First Author: : S.Beer BRAZIL

Co Author(s): :    M. Campos   N. Mayumi   F. Hirai   C. Francesconi Benicio   E. Nitschke   R. Santos

Abstract Details


To report safety, efficacy and outcomes of a refractive corneal inlay for presbyopia.


Federal University of São Paulo


Corneal Inlays (Presbia Flexivue Microlens™,Presbia LLC) were implanted in 31 non-dominant eye of emmetropic presbyopic patients (0.75 SE 1.00SE) after the creation of a 300 microns depth stromal pocket using a femtosecond laser. Patients were followed according to a clinical protocol, and included collection of visual acuity data, including refraction, anterior segment imaging analysis(Oculyzer,Alcon) and wavefront evaluation (Nidek OPD Scan).


After three years, 28 patients were examined. The mean UCVA improved to J 1 (log 0,3 to log0) in 78,95% of eyes treated with the inlay(versus, 90,3% in the first year follow up). All eyes improved four lines in all visits. Patients reported near vision to fair to excellent in 78,5%, (versus 96,5% in the first year). The UCDVA stayed stable along the time Three patients were explanted due to blurred vision for distance and near. One patient developed a superficial corneal ulcer after 20 months. Two patients underwent cataract removal. Four patient underwent inlay exchange to increase near power correction.


The Presbia Flexivue Microlens™ provided a presbyopia treatment by improving the near vision. Manageable complications may occur in the long term follow up and it seem to be stable in terms of histological activity and material compatibility over time.

Financial Disclosure:

One or more of the authors research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous